Sarah Gheuens - Mar 1, 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Medical Officer
Signature
/s/ William Cook, as attorney-in-fact for Sarah Gheuens
Stock symbol
AGIO
Transactions as of
Mar 1, 2023
Transactions value $
-$28,373
Form type
4
Date filed
3/3/2023, 03:05 PM
Previous filing
Feb 14, 2023
Next filing
Jun 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +3.83K +22.01% $0.00 21.3K Mar 1, 2023 Direct F1
transaction AGIO Common stock Tax liability -$28.4K -1.13K -5.34% $25.02 20.1K Mar 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Award $0 +12K $0.00 12K Mar 1, 2023 Common stock 12K Direct F2, F3
transaction AGIO Stock options (right to buy) Award $0 +44K $0.00 44K Mar 1, 2023 Common stock 44K $25.01 Direct F4
transaction AGIO Restricted stock units Options Exercise $0 -3.83K -33.33% $0.00 7.67K Mar 1, 2023 Common stock 3.83K Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 408 shares purchased through the Company's employee stock purchase plan.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
F4 This option was granted on March 1, 2023. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F5 The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.